Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06935786Not ApplicableRecruiting

SEDentary Lifestyle, Mortality and Major Adverse Clinical Outcomes in Chronic KIDney Disease

Role: collaborator

NCT05563571Not ApplicableUnknown

Hemiplegic Shoulder Pain Management Using Shoulder pRF and Corticosteroid Injection

Role: lead

NCT05520489Not ApplicableUnknown

Upper Limb Rehabilitation in First Year After Stroke Using Modern Treatment Strategies - a Single Case Study

Role: lead

NCT04288167Not ApplicableCompleted

Biochemical Diagnostics of Mild Traumatic Brain Injury (TBI) and Concussion in Children and Adolescents

Role: collaborator

NCT04774939Not ApplicableNot Yet Recruiting

EVLA and Optimal Timing of Sclerotherapy

Role: collaborator

NCT04737993Not ApplicableUnknown

Pulsed Radiofrequency of Suprascapular Nerve and Shoulder Joint for Chronic Shoulder Pain

Role: lead

All 6 trials loaded